Skip to main navigation Skip to search Skip to main content

Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases - practical recommendations. A position statement of ETFAD with external experts

J Ring, M Worm, A Wollenberg, J P Thyssen, T Jakob, L Klimek, C Bangert, S Barbarot, T Bieber, M S de Bruin-Weller, P V Chernyshov, S Christen-Zaech, M Cork, U Darsow, C Flohr, R Fölster-Holst, C Gelmetti, U Gieler, J Gutermuth, A HeratizadehD J Hijnen, L B von Kobyletzki, B Kunz, C Paul, L De Raeve, J Seneschal, D Simon, P I Spuls, J F Stalder, A Svensson, Z Szalai, A Taieb, A Torrelo, M Trzeciak, C Vestergaard, T Werfel, S Weidinger, M Deleuran

33 Citations (Scopus)
Original languageEnglish
JournalJournal of the European Academy of Dermatology and Venereology : JEADV
Volume35
Issue number6
Pages (from-to)e362-e365
ISSN0926-9959
DOIs
Publication statusPublished - Jun 2021

Keywords

  • Anaphylaxis
  • COVID-19
  • COVID-19 Vaccines
  • Dermatitis, Atopic/prevention & control
  • Humans
  • SARS-CoV-2
  • Vaccines

Cite this